Published July 2007 | Version v1
Journal article

Predicting patterns of glioma recurrence using diffusion tensor imaging

  • 1. University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Wolfson Brain Imaging Centre, Department of Clinical Neurosciences (United Kingdom)
  • 2. University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Academic Neurosurgery Unit (United Kingdom)
  • 3. University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, University Department of Oncology (United Kingdom)
  • 4. University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, University Department of Radiology (United Kingdom)

Description

Although multimodality therapy for high-grade gliomas is making some improvement in outcome, most patients will still die from their disease within a short time. We need tools that allow treatments to be tailored to an individual. In this study we used diffusion tensor imaging (DTI), a technique sensitive to subtle disruption of white-matter tracts due to tumour infiltration, to see if it can be used to predict patterns of glioma recurrence. In this study we imaged 26 patients with gliomas using DTI. Patients were imaged after 2 years or on symptomatic tumour recurrence. The diffusion tensor was split into its isotropic (p) and anisotropic (q) components, and these were plotted on T2-weighted images to show the pattern of DTI abnormality. This was compared to the pattern of recurrence. Three DTI patterns could be identified: (a) a diffuse pattern of abnormality where p exceeded q in all directions and was associated with diffuse increase in tumour size; (b) a localised pattern of abnormality where the tumour recurred in one particular direction; and (c) a pattern of minimal abnormality seen in some patients with or without evidence of recurrence. Diffusion tensor imaging is able to predict patterns of tumour recurrence and may allow better individualisation of tumour management and stratification for randomised controlled trials. (orig.)

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00330-006-0561-2

Additional details

Identifiers

Publishing Information

Journal Title
European Radiology
Journal Volume
17
Journal Issue
7
Journal Page Range
p. 1675-1684
ISSN
0938-7994
CODEN
EURAE3

INIS

Country of Publication
Germany
Country of Input or Organization
Germany
INIS RN
38091411
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BRAIN; DIAGNOSIS; GLIOMAS; IMAGES; NMR IMAGING
Descriptors DEC
BODY; CENTRAL NERVOUS SYSTEM; DIAGNOSTIC TECHNIQUES; DISEASES; NEOPLASMS; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; ORGANS